{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Sanmina Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance
Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown strong performance with an 89.52% return over the past year. Despite mixed technical indicators, the company has achieved significant growth, including a 375.01% increase over the last five years, reflecting its resilience in the market.
Sanmina Corp. Hits Day High with 7.21% Surge in Strong Intraday Performance
Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen a notable rise in stock performance, significantly outperforming the S&P 500 over various timeframes. The company demonstrates strong management efficiency, low debt levels, and robust financial health, supported by full institutional ownership.
Sanmina Corp. Hits Day Low of $123.64 Amid Price Pressure
Sanmina Corp., a small-cap in the Pharmaceuticals & Biotechnology sector, saw a notable stock decline on October 7, 2025. Despite this, the company has demonstrated strong performance over the past year, with significant increases in stock value, high return on equity, and solid cash flow metrics.
Sanmina Corp. Hits Day High with 22.72% Surge in Stock Price
Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown remarkable stock performance, significantly outperforming the S&P 500 over various time frames. The company boasts strong financial metrics, including a solid return on equity and record operating cash flow, with full institutional ownership indicating investor confidence.
Sanmina Corp. Hits New 52-Week High of USD 160.25, Up 111%
Sanmina Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. With a market capitalization of USD 11,620 million, the company demonstrates strong financial metrics, including a notable price-to-earnings ratio and a low debt-to-equity ratio, highlighting its solid financial foundation.
Sanmina Corp. Achieves 108.09% Return, Emerging as a Multibagger in Pharmaceuticals Sector
Sanmina Corp. has recently experienced a revision in its stock evaluation, reflecting its strong market position and impressive financial metrics. The company has outperformed the S&P 500 over the past year, showcasing resilience and growth. With high management efficiency and favorable debt management, Sanmina remains a notable player in the Pharmaceuticals & Biotechnology sector.
Is Sanmina Corp. technically bullish or bearish?
As of September 4, 2025, Sanmina Corp. is in a bullish trend supported by positive MACD and moving averages, despite mixed signals from Dow Theory and OBV, and has significantly outperformed the S&P 500 year-to-date.
Is Sanmina Corp. overvalued or undervalued?
As of July 28, 2025, Sanmina Corp. is considered very attractive and undervalued, with a P/E ratio of 32, strong performance outpacing the S&P 500, and metrics indicating a favorable position compared to peers.
Is Sanmina Corp. technically bullish or bearish?
As of May 12, 2025, Sanmina Corp. has shifted to a bullish technical trend, supported by strong indicators like a bullish MACD, Bollinger Bands, and moving averages, despite a mildly bearish OBV on the monthly chart.
Is Sanmina Corp. overvalued or undervalued?
As of April 28, 2025, Sanmina Corp. is considered undervalued with an attractive valuation grade, a P/E ratio of 32, and a year-to-date return of 21.20%, significantly outperforming the S&P 500's 2.44%.
Who are in the management team of Sanmina Corp.?
As of March 2022, Sanmina Corp.'s management team includes Mr. Jure Sola as Chairman and CEO, with Ms. Jacquelyn Ward as Lead Independent Director and several Independent Directors: Mr. Eugene Delaney, Mr. John Goldsberry, Ms. Rita Lane, and Mr. Joseph Licata.
What does Sanmina Corp. do?
Sanmina Corporation provides integrated manufacturing solutions and services in the Pharmaceuticals & Biotechnology industry, with net sales of $1.984 billion and a market cap of approximately $8.71 billion as of March 2025. Key metrics include a P/E ratio of 32.00 and a return on equity of 12.13%.
How big is Sanmina Corp.?
As of Jun 18, Sanmina Corp. has a market capitalization of $8.71 billion, with net sales of $7.85 billion and a net profit of $263.48 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
